05.01.2018 Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin.

Search

Rx drug information, pharmaceutical research, clinical trials, news, and more

Drugs By Name By Condition By Category Most Searched Ratings/Reviews Adverse Events Actives

Cleocin Vaginal (Clindamycin Vaginal) - Published Studies

Rx Info Potential patient preference for 3-day treatment of bacterial

Summary
vaginosis: responses to new suppository form of clindamycin.

Description and Author(s): Broumas AG, Basara LA

Clinical Pharmacology
Affiliation(s): New York Medical College, Valhalla, USA.
Indications and Dosage
Publication date & source: 2000-05, Adv Ther., 17(3):159-66.
Warnings and
Precautions Publication type: Clinical Trial; Randomized Controlled Trial

Side Effects and
Adverse Reactions
Drug Interactions,
Overdosage,
Contraindications,
Other Rx Info
News & Research
Published Studies
Curr't Clinical Trials
Treatment options for bacterial vaginosis (BV) include oral and topical formulations of
metronidazole or topical formulations of clindamycin. Opinions of a new vaginal suppository
form of clindamycin, administered for 3 days, were obtained in a survey of 96 women who
had been generally satisfied with their previous treatment. Following manipulation of the
clindamycin ovule and metronidazole vaginal gel, more respondents expressed a preference
for the ovule (52% vs 47%), and 54% preferred the ovule to the gel (44%) for possible future
use. The gel was rated easier to use, but the ovule was found to be less messy. After
manipulating both products, respondents read a profile of the ovule and identified the 3-day
course as its most beneficial feature, citing this reason as increasing their likelihood of
completing therapy with the ovule than with the gel. Approximately three fourths of the
Москва → Симферополь
respondents who initially preferred the gel switched their preference to the ovule after reading
(Крым)
the product profile. At that point, 86.5% of all respondents preferred the ovule. These results
suggest the potential for improved compliance with therapy for BV with the clindamycin ovule.
Index of Published Studies

Page last updated: 2006-01-31

Штумм - Ski Chalet

Kaltenbach Stumm О компании

-- advertisement --

Sovata - Casa
Borbála Vadászház
Превосходно 9.5

Peştera - Chalet
Ro
Превосходно 9.5

О Компании

http://www.druglib.com/abstract/br/broumas-ag_adv-ther_20000500.html 1/2
05.01.2018 Potential patient preference for 3-day treatment of bacterial vaginosis: responses to new suppository form of clindamycin.

Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017

http://www.druglib.com/abstract/br/broumas-ag_adv-ther_20000500.html 2/2